ABSTRACT
INTRODUCTION 59
Coccidioidomycosis, also known as Valley fever, is caused by a fungal pathogen endemic to the 60 San Joaquin Valley in California, Arizona, northern Mexico and arid areas of South America [1] . 61
Population expansion, travel, improved detection and/or climate changes appear to be 62 contributing to an expanding endemic region. 40% of those infected develop symptomatic 63 pneumonia that typically resolves without anti-fungal therapy, although disease can become 64 chronic and disseminate outside the lungs [1] . Persistent coccidioidomycosis is thought to be due 65 to poor or ineffective cellular immunity. 66 67 Cellular immune responses are critical for effective immunity to Coccidioides infection [2, 3] . 68
Early mouse studies indicate a need for T helper 1 (Th1) responses in protective immunity [4] . Leukocyte subset total numbers were calculated using counting beads in combination with each 153 leukocyte percentage determined by flow cytometry. Statistical analyses were performed using 154
Prism software v6.0 (GraphPad Software). One-way ANOVA with Bonferroni correction was 155 used to compare multiple groups with a 95% confidence interval. The Fisher's exact test was 156 used to compare the distribution of groups and percentages. PCA and CHAID analyses were 157 performed using XLSTAT. 158
159

RESULTS: 160
Patient characteristics 161
Thirty pediatric patients with a diagnosis of coccidioidomycosis (15 inpatients and 15 162 outpatients) and 20 healthy controls were enrolled. One inpatient died due to disease severity and 163 was excluded from analysis. Of the thirty patients with coccidioidomycosis, 25 had pulmonary 164 involvement and five had disseminated disease including the deceased patient. Resolved disease 165 was observed in 13 (44.8%) patients and persistent disease in 16 (55.2%), including 12 with 166 pulmonary and 4 with disseminated disease. 167 168 Age and ethnicity, as well as the incidence of chest pain, night sweats, weight loss and fatigue 169 symptoms were similar between the groups, and did not correlate with disease outcome (Table 1  170 and Table 2 ). More females than male patients were enrolled in the study, but this is unlikely tocorrelated with a better disease prognosis (p=0.0722). Evaluating complete blood count (CBC) 174 measurements, inpatients had higher neutrophil, eosinophil, WBC and platelet numbers, and 175 lower lymphocyte numbers compared to outpatients (Supplemental Figure 1) . Eosinophil, 176 platelet and creatinine (Cr) levels were elevated and lymphocyte counts reduced in patients with 177 persistent disease compared to patients that resolved infection. Although some CBC parameters 178
were significantly different between the groups, there was considerable overlap in values and 179 these small variations would be difficult to use in predicting disease outcome. Serum IgM, IgG 180 and antibody titers from Coccidioides enzyme immunoassay and complement fixation (CF) 181 assays did not correlate with disease outcome, and were not different between inpatient and 182 outpatients (Supplemental Table 3 ). 183 184 Analysis of immune parameters based on hospital status revealed several differences between 185 inpatients and outpatients in both innate and adaptive responses. Plasmacytoid dendritic cell 186 frequency was reduced in inpatients relative to healthy controls and outpatients ( Figure 1A) . 187
CD4
+ , CD8 + and B cell frequency was reduced in inpatients, and mild elevation of cytokines ( Figure 3A) . As cytokines were evaluated in serum, and not from stimulated cell 209 supernatants, most cytokines were expressed at just above the limit of detection (LOD). IL-1α, 210 IL-1β, IL-5, IL-12p70, IL-21 and IL-22 were below the LOD for all patients (not shown). 211
Significant differences in IL-6, IL-18 and IL-12, and mild difference in IL-10, were observed 212 between patients with resolved and persistent disease, and all of these were increased relative to 213 healthy controls ( Figure 3B ). IL-6, IL-18 and IL-12 are produced by antigen presenting cells and 214 promote T effector differentiation. IL-10, an immunosuppressive cytokine, is expressed bydifferentiation and function [25, 26] . 217
218
Predictive biomarkers of disease outcome identified 219
To identify predictive biomarkers we performed principle component analysis (PCA) using all 220 non-diagnostic clinical, immune population and cytokine parameters. PCA analysis separated 221 patients from healthy controls, and inpatients from outpatients, but was unable to distinguish 222 patients with resolved versus persistent disease ( Figure 4A ). PCA comparison, using all 223 parameters, only described 31.9% of variation in the hospital status data and 26.3% of variation 224 in the disease outcome data, indicating that some parameters are too variable to include as a 225 means to distinguish patients. Chi-square automatic interaction detection (CHAID), a decision 226 tree technique, was used to define a predictive method for disease outcome. O u t p a t i e n t I n p a t i e n t C o n t r o l O u t p a t i e n t I n p a t i e n t C o n t r o l O u t p a t i e n t I n p a t i e n t C o n t r o l O u t p a t i e n t I n p a t i e n t C o n t r o l O u t p a t i e n t I n p a t i e n t C o n t r o l O u t p a t i e n t I n p a t i e n t C o n t r o l O u t p a t i e n t I n p a t i e n t C o n t r o l O u t p a t i e n t I n p a t i e n t C o n t r o l O u t p a t i e n t I n p a t i e n t C o n t r o l O u t p a t i e n t I n p a t i e n t C o n t r o l O u t p a t i e n t I n p a t i e n t C o n t r o l O u t p a t i e n t I n p a t i e n t 
